The impacts of the National Medication Price-Negotiated Policy on the financial burden of cancer patients in Shandong province, China: an interrupted time series analysis

Yi Ding,Chao Zheng,Xiaolin Wei,Qi Zhang,Qiang Sun
DOI: https://doi.org/10.1186/s12889-022-14525-7
IF: 4.5
2022-12-17
BMC Public Health
Abstract:In order to further regulate the price of anticancer medication and alleviate the financial burden of cancer patients, the Chinese government implemented the National Medication Price-Negotiated Policy (NMPNP) in 2017. This study aims to assess the impacts of implementation of the NMPNP on the access of anticancer medication and the financial burden for cancer patients in Shandong province, and to provide evidence to inform the design of similar policies in other developing countries.
public, environmental & occupational health
What problem does this paper attempt to address?